Answers are grounded in this paper and cite their sources.
Retrospective study identifies early mortality predictors in myositis/myasthenia patients using immune checkpoint inhibitors, indicating critical risk factors.
To identify predictors of early mortality (within 30 days) in patients with myositis/myasthenia (MM) associated with immune checkpoint inhibitors (ICI).
No takes yet. Share an insight, caveat, or question.
Fargas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: